Nair, A. V.; James, S.; Jain, V.

The genus Mycobacterium is increasingly recognized as a major clinical concern due to diseases such as tuberculosis, along with the emergence of antimicrobial-resistant strains, underscoring the urgent need for advanced genetic tools to study mycobacterial biology and pathogenesis. Progress in this area relies heavily on the functional characterization of previously unannotated genes, which necessitates tightly regulated expression systems. Here, we report the development of an improved tetracycline-regulated vector platform, comprising the episomal pM(R)T2 and integrative pMI(R)T2 series, which builds upon the previously described pMT vector system. The pMT2 vector series incorporates a fine-tuned TetRO system for enhanced transcriptional control. The pMT2 vectors function as tetracycline-inducible systems, whereas the pMRT2 variants utilize a reverse tetracycline repressor (RevTetR) to enable tetracycline-repressible gene regulation. Additionally, the integrative variant, pMI(R)T2 switches the oriM element with the integrase and attP sites derived from mycobacteriophage L5, facilitating stable genomic integration and controlled expression of concentration-sensitive genes, including toxins. To expand the selection flexibility, the pAN(R)Tet series replaces the kanamycin resistance cassette with a hygromycin resistance cassette. Functional validation of gene regulation in M. smegmatis and M. bovis BCG shows that both TetR and RevTetR systems provide reliable inducible and repressible controls, respectively, upon anhydrotetracycline addition. Taken together, these vectors constitute a versatile, tightly regulated genetic toolkit with significant potential to accelerate research and therapeutic development in mycobacterial systems.